- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03500432
A Study of a New Local Anesthesia Method for Transperineal Prostate Biopsy
April 14, 2018 updated by: yinghao Sun, Second Military Medical University
A Novel, Repeatable, and Effective Local Anesthesia Method for Transperineal Prostate biopsy-a Single Center Randomized Controlled Trial
In comparison with transrectal prostate biopsy, transperineal prostate biopsy has the advantage of better sampling from the anterior area, low risk of infection, and no rectal bleeding.
The main problems associated with the transperineal method are pain control and additional general or spinal anesthesia.
Three types of anesthesia have been reported for transperineal prostate biopsy: (1) spinal anesthesia; (2) general anesthesia; and (3) local anesthesia.
From the viewpoint of patient selection (general anesthesia is contraindicated in some patients) and medical cost, local anesthesia is the most suitable choice for prostate biopsy.
Periprostatic block is the standard method of local anesthesia for this procedure.
However, periprostatic block is insufficient for transperineal prostate biopsy due to high pain sensitivity in this region.
A number of new methods to eliminate pain have been reported, including (1) periapical triangle (PAT) block, (2) paraprostatic plus sexual nerve block, and (3) periprostatic block plus pudendal block.However, there is no anatomical basis for some of these methods, and there have been no randomized controlled trials to evaluate their effectiveness, and some methods are technically difficult to learn.
In the previous perineal nerve autopsy, we found that there are two branches leading into the prostate and anterior lateral prostatic tissue, which is the main site of puncture pain.
There is a fixed position where the two branches appear.
Therefore, this anatomical position block may be a useful site for local anesthesia.
We named this location the 'transperineal prostate biopsy local anesthesia switch' (abbreviated as TPA switch).
In order to validate its effect, we organized this clinical trail.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Ninety patients scheduled for prostate biopsy will include in this study.
The clinical trial validation process will be as follows: (1) all patients are randomly divided into three groups (Figure 1): group 1, subcutaneous local anesthesia+periprostatic block; group 2, subcutaneous local anesthesia+periapical triangle (PAT) block; group 3, subcutaneous local anesthesia+TPA switch (transperineal prostate biopsy local anesthesia switch) block; VAS scores for each puncture and complications will be recorded.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200000
- Changhai Hospital,Second Military Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 88 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- 1. ready to be performed transperineal prostate biopsy; 2. fully understand the protocol and aggree to undergo prostate biopsy with local anesthesia which might be elder methods or new experimental method.
Exclusion Criteria:
- 1.do not have the history of anaphylaxis or local anesthetic intoxation; 2. cardiac dysfunction or coagulation dysfunction; 3. Rectal disease which can not allowed to plug the ultrasound probe in; 4.do not fully understand our protocol; 5. do not aggree our protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: periprostatic group
local anesthesia of trnasperineal prostate biopsy with subcutaneous local anesthesia+periprostatic block
|
three different block site with lidocaine
Other Names:
|
Active Comparator: PAT group
local anesthesia of trnasperineal prostate biopsy with subcutaneous local anesthesia+periapical triangle (PAT) block
|
three different block site with lidocaine
Other Names:
|
Experimental: TPA switch group
local anesthesia of trnasperineal prostate biopsy with subcutaneous local anesthesia+TPA switch (transperineal prostate biopsy local anesthesia switch) block
|
three different block site with lidocaine
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
highest VAS scores
Time Frame: ask patients in 2 minutes after prostate biopsy
|
the highest VAS (visual analogue scale) scores during the procedure in one patient.
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.
It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
VAS is the most common pain scale for quantification of endometriosis-related pain and skin graft donor site-related pain.
In detail, it is a 10-point categorical scale pain measurement.
The score ranges from 0 to 10, and the no pain is 0, and highest pain is 10.
|
ask patients in 2 minutes after prostate biopsy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complications
Time Frame: during the procedures and 1 days after the procedure
|
Complications associated with local anesthesia.
The complication include: bleeding, intoxation of local anesthetic and anaphylaxis of local anesthetic.
|
during the procedures and 1 days after the procedure
|
main VAS scores
Time Frame: ask patients in 2 minutes after prostate biopsy
|
the main VAS (visual analogue scale) scores during the procedure in one patient.
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.
It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
VAS is the most common pain scale for quantification of endometriosis-related pain and skin graft donor site-related pain.
In detail, it is a 10-point categorical scale pain measurement.
The score ranges from 0 to 10, and the no pain is 0, and highest pain is 10.
|
ask patients in 2 minutes after prostate biopsy
|
patients movement
Time Frame: during the transperineal prostate biopsy
|
During the procedure if there is movement of the body which will affect the process of prostate biopsy.
|
during the transperineal prostate biopsy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Yinghao 2 Sun, professor, Second Military Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 2, 2018
Primary Completion (Actual)
March 22, 2018
Study Completion (Actual)
March 22, 2018
Study Registration Dates
First Submitted
March 21, 2018
First Submitted That Met QC Criteria
April 14, 2018
First Posted (Actual)
April 18, 2018
Study Record Updates
Last Update Posted (Actual)
April 18, 2018
Last Update Submitted That Met QC Criteria
April 14, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- SP-FA2018001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Local Anesthesia
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMNot yet recruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | AnesthesiaGermany
-
Grünenthal GmbHTerminatedAnalgesia | Anesthesia, Local | AnesthesiaNetherlands
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruiting
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
University Health Network, TorontoRecruiting
-
Kfir SiagNot yet recruiting
-
Hams Hamed AbdelrahmanCompleted
-
University of BaghdadActive, not recruiting
Clinical Trials on local anesthesia of trnasperineal prostate biopsy
-
Jonsson Comprehensive Cancer CenterWithdrawnStage III Prostate AdenocarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Terminated
-
Fujian Medical University Union HospitalRecruiting
-
Heinrich-Heine University, DuesseldorfUniversity Hospital, Essen; University Hospital Muenster; German Cancer Research... and other collaboratorsNot yet recruiting
-
Johann Wolfgang Goethe University HospitalUnknownBrain Lesion, Stereotactic BiopsyGermany
-
HaEmek Medical Center, IsraelMeir Medical Center; Bnai Zion Medical Center; Barzilai Medical CenterUnknownBenign Prostatic Hyperplasia | Prostate CancerIsrael
-
Thomas Jefferson UniversityGE Healthcare; Amsterdam UMC, location VUmc; Eigen; Eindhoven University of TechnologyNot yet recruitingProstate CarcinomaUnited States, Netherlands
-
University College, LondonRecruitingUrinary Incontinence | Prostate Cancer | Male Erectile Disorder | Therapy-related ToxicityUnited Kingdom
-
University Hospital Virgen de las NievesHospital Universitario Reina Sofia de Cordoba; Hospitales Universitarios Virgen... and other collaboratorsRecruitingRecurrent Prostate Cancer | Cryotherapy | High Intensity Focused UltrasoundsSpain, France